
| Revenue | $1 - $10 million See Exact Annual Revenue |
|---|---|
| Employees | 1 - 10Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Address | 924 Valmont St. New Orleans, LA 70115 |
| Waterborne | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $1 - $10 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Waterborne P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| WATERBORNE Laboratory equipment and supplies, namely diluents, slides, counterstains, vials, mounting mediums, and buffers for use in in the fields of environmental parasitology and water testing | 01/27/2015 |
| CRYPT-A-GLO Assay kits and testing kits consisting of biological, chemical and biochemical reagents, compounds and preparations for purposes of detecting, diagnosing and analyzing bacteria, parasites and pathogens in water and the environment; fluorescent antibody kits comprising biological, chemical and biochemical reagents, compounds and preparations, for purposes of detecting, diagnosing and analyzing bacteria, parasites and pathogens in water testing and clinical diagnosis; fluorescein-labeled monoclonal antibody reagent for direct immunofluorescence detection of cryptosporidium oocysts in water samples | 01/27/2015 |
| GIARDI-A-GLO Assay kits and testing kits consisting of biological, chemical and biochemical reagents, compounds and preparations for purposes of detecting, diagnosing and analyzing bacteria, parasites and pathogens in water and the environment; fluorescent antibody kits comprising biological, chemical and biochemical reagents, compounds and preparations for purposes of detecting, diagnosing and analyzing bacteria, parasites and pathogens in water testing and clinical diagnosis; fluorescein-labeled monoclonal antibody reagent for direct immunofluorescence detection of giardia in water samples | 01/27/2015 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| AXOSIM | New Orleans, LA | 100 |
| OBATALA SCIENCES | New Orleans, LA | 44 |
| LOUISIANA GENE THERAPY/LCRC | New Orleans, LA | 40 |
| RDA | New Orleans, LA | 27 |
| NONPROFIT KNOWLEDGE WORKS | New Orleans, LA | 13 |
| WATERBORNE | New Orleans, LA | 9 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |